Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 6/2022

06.05.2022 | Review Article

Clinicopathological features of gastric cancer after pancreaticoduodenectomy: reporting of three institutional cases and review of the global literature

verfasst von: Tatsuaki Sumiyoshi, Kenichiro Uemura, Naru Kondo, Kenjiro Okada, Shingo Seo, Hiroyuki Otsuka, Shinya Takahashi

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 6/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Gastric cancer after pancreaticoduodenectomy was firstly reported in 1995, and the number of reports about this topic has increased in the past years. This review aimed to elucidate the clinicopathological features of this disease.

Methods

Data for 32 cases were obtained using literature search, and three cases in our institution were added.

Results

Twenty cases were reported from Japan, and fifteen cases were from the Western countries (Germany: 1 case, France: 2 cases, USA: 12 cases). In Japanese and the Western cases, the most dominant indication for pancreaticoduodenectomy was distal bile duct cancer and pancreatic ductal adenocarcinoma, respectively. The most frequently applied procedure of pancreaticoduodenectomy was pylorus-preserving pancreatoduodenectomy with pancreaticogastrostomy and pancreaticoduodenectomy with pancreaticojejunostomy, respectively. The median length of time interval from pancreaticoduodenectomy to GC detection tended to be shorter in the Japanese cases (61.5 months vs. 115 months). Of all cases, thirteen (37.1%) patients with gastric cancer showed no abdominal symptoms, and eight were diagnosed at regular gastroscopy. Surgical gastrectomy was performed in 30 patients, and among them, concomitant pancreatectomy was performed in six patients. Four patients received reanastomosis of remnant pancreas using pancreaticojejunostomy. Twenty-two (73.3%) patients had undifferentiated carcinomas, and stage 1, 2, 3, and 4 cancer was identified in 14, six, six, and four patients, respectively. All eight patients who had received routine gastroscopy were T1N0M0 stage 1.

Conclusion

Gastric cancers after pancreaticoduodenectomy including newly reported Japanese cases and our institutional cases were reviewed to make Japanese studies available to a broader scientific audience. Further investigation is necessary to elucidate the most important carcinogens among the various potential local and systemic factors.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Cameron JL, He J (2015) Two thousand consecutive pancreaticoduodenectomies. J Am Coll Surg 220:530–536PubMedCrossRef Cameron JL, He J (2015) Two thousand consecutive pancreaticoduodenectomies. J Am Coll Surg 220:530–536PubMedCrossRef
2.
Zurück zum Zitat Motoi F, Kosuge T, Ueno H et al (2019) Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05). Jpn J Clin Oncol 49:190–194PubMedCrossRef Motoi F, Kosuge T, Ueno H et al (2019) Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05). Jpn J Clin Oncol 49:190–194PubMedCrossRef
3.
Zurück zum Zitat Uesaka K, Boku N, Fukutom A et al (2016) Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). Lancet 388:248–257PubMedCrossRef Uesaka K, Boku N, Fukutom A et al (2016) Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). Lancet 388:248–257PubMedCrossRef
4.
Zurück zum Zitat Neoptolemos JP, Palmer DH, Ghaneh P et al (2017) Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet 389:1011–1112PubMedCrossRef Neoptolemos JP, Palmer DH, Ghaneh P et al (2017) Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet 389:1011–1112PubMedCrossRef
5.
Zurück zum Zitat Takeno S, Hashimoto T, Maki K et al (2014) Gastric cancer arising from the remnant stomach after distal gastrectomy: a review. World J Gastroenterol 20:13734–13740PubMedPubMedCentralCrossRef Takeno S, Hashimoto T, Maki K et al (2014) Gastric cancer arising from the remnant stomach after distal gastrectomy: a review. World J Gastroenterol 20:13734–13740PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Lundegardh G, Adami HO, Helmick (1988) Stomach cancer after partial gastrectomy for benign ulcer disease. N Engl J Med 319:195–200PubMedCrossRef Lundegardh G, Adami HO, Helmick (1988) Stomach cancer after partial gastrectomy for benign ulcer disease. N Engl J Med 319:195–200PubMedCrossRef
7.
Zurück zum Zitat Tersmette AC, Offerhaus GJ, Tersmette KW et al (1990) Meta-analysis of the risk of gastric stump cancer: detection of high risk patient subsets for stomach cancer after remote partial gastrectomy for benign conditions. Cancer Res 50:6486–6489PubMed Tersmette AC, Offerhaus GJ, Tersmette KW et al (1990) Meta-analysis of the risk of gastric stump cancer: detection of high risk patient subsets for stomach cancer after remote partial gastrectomy for benign conditions. Cancer Res 50:6486–6489PubMed
8.
Zurück zum Zitat Sonoda K, Samdani RT, Ikoma N (2019) Gastric cancer in the remnant stomach after pancreaticoduodenectomy: a case series. J Surg Oncol 120:1137–1141PubMedCrossRef Sonoda K, Samdani RT, Ikoma N (2019) Gastric cancer in the remnant stomach after pancreaticoduodenectomy: a case series. J Surg Oncol 120:1137–1141PubMedCrossRef
9.
Zurück zum Zitat Pflüger MJ, Felsenstein M, Schmocker R et al (2020) Gastric cancer following pancreaticoduodenectomy: experience from a high-volume center and review of existing literature. Surg Open Sci 2:32–40PubMedPubMedCentralCrossRef Pflüger MJ, Felsenstein M, Schmocker R et al (2020) Gastric cancer following pancreaticoduodenectomy: experience from a high-volume center and review of existing literature. Surg Open Sci 2:32–40PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Tatsuzawa Y, Osari A, Uno Y et al (1995) A case of early gastric cancer after pylorus-preserving pancreatoduodenectomy. J Jpn Pract Surg Soc 56:2084–2088 Tatsuzawa Y, Osari A, Uno Y et al (1995) A case of early gastric cancer after pylorus-preserving pancreatoduodenectomy. J Jpn Pract Surg Soc 56:2084–2088
11.
Zurück zum Zitat Kaneda K, Nomura H, Fujiwara H et al (1996) A case of early gastric cancer after pylorus-preserving pancreatoduodenectomy. Acta Med Kinki Univ 21:263–268 Kaneda K, Nomura H, Fujiwara H et al (1996) A case of early gastric cancer after pylorus-preserving pancreatoduodenectomy. Acta Med Kinki Univ 21:263–268
12.
Zurück zum Zitat Manabe T, Nishihara K, Kurokawa Y et al (2001) A collision tumor composed of adenocarcinoma and malignant lymphoma in the remnant stomach after pancreatoduodenectomy: report of a case. Surg Today 31:450–453PubMedCrossRef Manabe T, Nishihara K, Kurokawa Y et al (2001) A collision tumor composed of adenocarcinoma and malignant lymphoma in the remnant stomach after pancreatoduodenectomy: report of a case. Surg Today 31:450–453PubMedCrossRef
13.
Zurück zum Zitat Ohashi N, Tamaki H, Sanda T et al (2001) Development of carcinoma of the stomach after pylorus-preserving pancreatoduodenectomy (PPPD) for early carcinoma of the papilla of Vater: case report. J Jpn Pancreas Soc 16:42–47 Ohashi N, Tamaki H, Sanda T et al (2001) Development of carcinoma of the stomach after pylorus-preserving pancreatoduodenectomy (PPPD) for early carcinoma of the papilla of Vater: case report. J Jpn Pancreas Soc 16:42–47
14.
Zurück zum Zitat Emoto T, Yoshikawa K, Dousei T et al (2002) A case of early gastric cancer after pylorus-preserving pancreatoduodenectomy. Jpn J Gastroenterol Surg 35:277–281CrossRef Emoto T, Yoshikawa K, Dousei T et al (2002) A case of early gastric cancer after pylorus-preserving pancreatoduodenectomy. Jpn J Gastroenterol Surg 35:277–281CrossRef
15.
Zurück zum Zitat Mihara Y, Kubota K, Nemoto T et al (2005) Gastric cancer developing in the stomach after pylorus-preserving pancreaticoduodenectomy with pancreaticogastrostomy: case report and review of the literature. J Gastrointest Surg 9:498–502PubMedCrossRef Mihara Y, Kubota K, Nemoto T et al (2005) Gastric cancer developing in the stomach after pylorus-preserving pancreaticoduodenectomy with pancreaticogastrostomy: case report and review of the literature. J Gastrointest Surg 9:498–502PubMedCrossRef
16.
Zurück zum Zitat Tsukahara A, Koyama S, Hatayama S et al (2006) A case of early gastric cancer after pylorus-preserving pancreatoduodenectomy. Operation 60:259–262 (in Japanese) Tsukahara A, Koyama S, Hatayama S et al (2006) A case of early gastric cancer after pylorus-preserving pancreatoduodenectomy. Operation 60:259–262 (in Japanese)
17.
Zurück zum Zitat Furukawa K, Oguma H, Yamamoto M (2007) A case of early gastric cancer revealed 7 years after PPPD. Nihon Gekakei Rengo Gakkaishi 32:44–47CrossRef Furukawa K, Oguma H, Yamamoto M (2007) A case of early gastric cancer revealed 7 years after PPPD. Nihon Gekakei Rengo Gakkaishi 32:44–47CrossRef
18.
Zurück zum Zitat Sunagawa H, Taskahashi I, Nishizaki T (2013) A case of gastric cancer after pylorus-preserving pancreatoduodenectomy with pancreaticogastrostomy. Rinsho To Kenkyu 90:181–184 (in Japanese) Sunagawa H, Taskahashi I, Nishizaki T (2013) A case of gastric cancer after pylorus-preserving pancreatoduodenectomy with pancreaticogastrostomy. Rinsho To Kenkyu 90:181–184 (in Japanese)
19.
Zurück zum Zitat Yamada M, Nakai K, Inoue K et al (2014) A case report of residual gastric cancer 15 years after pancreatoduodenectomy with modified child’s reconstruction. Gan To Kagaku Ryoho 41:2439–2441PubMed Yamada M, Nakai K, Inoue K et al (2014) A case report of residual gastric cancer 15 years after pancreatoduodenectomy with modified child’s reconstruction. Gan To Kagaku Ryoho 41:2439–2441PubMed
20.
Zurück zum Zitat Sakaki M, Taniguchi H, Yamano T (2015) A case of early gastric cancer with intraductal papillary mucinous carcinoma (IPMC) recurrence developing at the site of pancreaticogastrostomy (PG) after pancreaticoduodenectomy (PD) for IPMC of the pancreas head. J Kyoto Pref Univ Med 124:265–276 Sakaki M, Taniguchi H, Yamano T (2015) A case of early gastric cancer with intraductal papillary mucinous carcinoma (IPMC) recurrence developing at the site of pancreaticogastrostomy (PG) after pancreaticoduodenectomy (PD) for IPMC of the pancreas head. J Kyoto Pref Univ Med 124:265–276
21.
Zurück zum Zitat Hiramatsu K, Kato T, Shibata Y et al (2016) Five cases of early gastric cancer after pylorus-preserving pancreatoduodenectomy with pancreaticogastrostomy. Operation 70:1113–1120 Hiramatsu K, Kato T, Shibata Y et al (2016) Five cases of early gastric cancer after pylorus-preserving pancreatoduodenectomy with pancreaticogastrostomy. Operation 70:1113–1120
22.
Zurück zum Zitat Kujiraoka M, Asai K, Watanabe R et al (2019) A case of resection of early gastric cancer developing after pancreaticoduodenectomy with pancreaticogastrostomy. Nihon Gekakei Rengo Gakkaishi 44:209–216CrossRef Kujiraoka M, Asai K, Watanabe R et al (2019) A case of resection of early gastric cancer developing after pancreaticoduodenectomy with pancreaticogastrostomy. Nihon Gekakei Rengo Gakkaishi 44:209–216CrossRef
23.
Zurück zum Zitat Kassahun WT, Lamesch P, Wittekind C et al (2008) Signet-ring cell carcinoma arising in the gastric stump after duodenopancreatectomy for ductal adenocarcinoma of the pancreas: a case report. Clin Med Oncol 2:109–112PubMedPubMedCentral Kassahun WT, Lamesch P, Wittekind C et al (2008) Signet-ring cell carcinoma arising in the gastric stump after duodenopancreatectomy for ductal adenocarcinoma of the pancreas: a case report. Clin Med Oncol 2:109–112PubMedPubMedCentral
24.
Zurück zum Zitat Bouquot M, Dokmak S, Barbier L et al (2017) Gastric stump carcinoma as a long-term complication of pancreaticoduodenectomy: report of two cases and review of the English literature. BMC Gastroenterol 17:117PubMedPubMedCentralCrossRef Bouquot M, Dokmak S, Barbier L et al (2017) Gastric stump carcinoma as a long-term complication of pancreaticoduodenectomy: report of two cases and review of the English literature. BMC Gastroenterol 17:117PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Tempero MA, Malafa MP, Al-Hawary M et al (2017) Pancreatic adenocarcinoma, version 2.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 15:1028–1061PubMedCrossRef Tempero MA, Malafa MP, Al-Hawary M et al (2017) Pancreatic adenocarcinoma, version 2.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 15:1028–1061PubMedCrossRef
26.
Zurück zum Zitat Oettle H, Post S, Neuhaus P et al (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297:267–277PubMedCrossRef Oettle H, Post S, Neuhaus P et al (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297:267–277PubMedCrossRef
27.
Zurück zum Zitat Hsu CC, Herman JM, Corsini MM et al (2010) Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital–Mayo Clinic collaborative study. Ann Surg Oncol 17:981–990PubMedPubMedCentralCrossRef Hsu CC, Herman JM, Corsini MM et al (2010) Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital–Mayo Clinic collaborative study. Ann Surg Oncol 17:981–990PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Ahsan H, Neugut AI (1998) Radiation therapy for breast cancer and increased risk for esophageal carcinoma. Ann Intern Med 128:114–117PubMedCrossRef Ahsan H, Neugut AI (1998) Radiation therapy for breast cancer and increased risk for esophageal carcinoma. Ann Intern Med 128:114–117PubMedCrossRef
29.
Zurück zum Zitat Hauptmann M, Fossa SD, Stovall M et al (2015) Increased stomach cancer risk following radiotherapy for testicular cancer. Br J Cancer 112:44–51PubMedCrossRef Hauptmann M, Fossa SD, Stovall M et al (2015) Increased stomach cancer risk following radiotherapy for testicular cancer. Br J Cancer 112:44–51PubMedCrossRef
31.
Zurück zum Zitat Hagiwara T, Mukaisho K, Nakayama T et al (2011) Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori. Gut 60:624–630PubMedCrossRef Hagiwara T, Mukaisho K, Nakayama T et al (2011) Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori. Gut 60:624–630PubMedCrossRef
32.
Zurück zum Zitat Cheung KS, Chan EW, Wong AYS et al (2018) Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study. Gut 67:28–35PubMedCrossRef Cheung KS, Chan EW, Wong AYS et al (2018) Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study. Gut 67:28–35PubMedCrossRef
33.
Zurück zum Zitat Seo SI, Park CH, You SC et al (2021) Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea. Gut 70:2066–2075PubMedCrossRef Seo SI, Park CH, You SC et al (2021) Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea. Gut 70:2066–2075PubMedCrossRef
34.
Zurück zum Zitat Suemori K, Kojima T, Mimura T (2021) Investigation of marginal ulcer after pancreatoduodenectomy. Nihon Shokakibyo Gakkai Zasshi 118:61–69PubMed Suemori K, Kojima T, Mimura T (2021) Investigation of marginal ulcer after pancreatoduodenectomy. Nihon Shokakibyo Gakkai Zasshi 118:61–69PubMed
35.
Zurück zum Zitat Imai S, Ooki T, Murata-Kamiya N et al (2021) Helicobacter pylori CagA elicits BRCAness to induce genome instability that may underlie bacterial gastric carcinogenesis. Cell Host Microbe 29:941–958PubMedCrossRef Imai S, Ooki T, Murata-Kamiya N et al (2021) Helicobacter pylori CagA elicits BRCAness to induce genome instability that may underlie bacterial gastric carcinogenesis. Cell Host Microbe 29:941–958PubMedCrossRef
Metadaten
Titel
Clinicopathological features of gastric cancer after pancreaticoduodenectomy: reporting of three institutional cases and review of the global literature
verfasst von
Tatsuaki Sumiyoshi
Kenichiro Uemura
Naru Kondo
Kenjiro Okada
Shingo Seo
Hiroyuki Otsuka
Shinya Takahashi
Publikationsdatum
06.05.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 6/2022
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-022-02524-6

Weitere Artikel der Ausgabe 6/2022

Langenbeck's Archives of Surgery 6/2022 Zur Ausgabe

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.